source
- Anthropic’s Claude Science signals AI firms are taking health research seriouslyBrittany Trang, a health‑tech reporter, notes that Anthropic’s new Claude Science model shows major AI developers are turning toward genuine scientific work rather than only high‑profile demos. Th…
- Sanofi’s Pompe disease enzyme therapy clears Phase 3 in infants, opening US label expansionSanofi announced that its next‑generation enzyme replacement therapy for Pompe disease met its primary endpoints in a registrational Phase 3 trial involving infants with the severe infantile‑onset…